JP2002512794A - ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み - Google Patents
ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込みInfo
- Publication number
- JP2002512794A JP2002512794A JP2000546001A JP2000546001A JP2002512794A JP 2002512794 A JP2002512794 A JP 2002512794A JP 2000546001 A JP2000546001 A JP 2000546001A JP 2000546001 A JP2000546001 A JP 2000546001A JP 2002512794 A JP2002512794 A JP 2002512794A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- rna
- acid molecule
- enzymatic nucleic
- rna polymerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/345—Spatial arrangement of the modifications having at least two different backbone modifications
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8372798P | 1998-04-29 | 1998-04-29 | |
US60/083,727 | 1998-04-29 | ||
US09/186,675 US6127535A (en) | 1997-11-05 | 1998-11-04 | Nucleoside triphosphates and their incorporation into oligonucleotides |
US09/186,675 | 1998-11-04 | ||
PCT/US1999/009348 WO1999055857A2 (fr) | 1998-04-29 | 1999-04-28 | Nucleoside triphosphates et leur integration aux ribozymes |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003429834A Division JP2004147666A (ja) | 1998-04-29 | 2003-12-25 | ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002512794A true JP2002512794A (ja) | 2002-05-08 |
Family
ID=26769652
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000546001A Pending JP2002512794A (ja) | 1998-04-29 | 1999-04-28 | ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み |
JP2003429834A Pending JP2004147666A (ja) | 1998-04-29 | 2003-12-25 | ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003429834A Pending JP2004147666A (ja) | 1998-04-29 | 2003-12-25 | ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1073732A2 (fr) |
JP (2) | JP2002512794A (fr) |
AU (1) | AU751480B2 (fr) |
CA (1) | CA2330574A1 (fr) |
WO (1) | WO1999055857A2 (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7034009B2 (en) | 1995-10-26 | 2006-04-25 | Sirna Therapeutics, Inc. | Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
EP1071753A2 (fr) | 1998-04-20 | 2001-01-31 | Ribozyme Pharmaceuticals, Inc. | Molecules d'acides nucleiques presentant de nouvelles compositions chimiques capables de moduler l'expression genique |
AU4589000A (en) | 1999-04-30 | 2000-11-17 | Cyclops Genome Sciences Limited | Polynucleotides |
US7491805B2 (en) | 2001-05-18 | 2009-02-17 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
US7833992B2 (en) | 2001-05-18 | 2010-11-16 | Merck Sharpe & Dohme | Conjugates and compositions for cellular delivery |
WO2002081628A2 (fr) | 2001-04-05 | 2002-10-17 | Ribozyme Pharmaceuticals, Incorporated | Modulation de l'expression genique associee a la proliferation inflammatoire et a la croissance de neurites, par des procedes faisant intervenir l'acide nucleique |
CA2397813A1 (fr) * | 2000-02-24 | 2001-08-30 | Ira Von Carlowitz | Methode et reactif d'inhibition de grid |
AU2001283222A1 (en) * | 2000-08-09 | 2002-02-18 | Ribozyme Pharmaceuticals, Incorporated | Method and reagent for the inhibition of calcium activated chloride channel-1 (clca-1) |
AU2001286959B2 (en) | 2000-09-01 | 2007-09-06 | Ribozyme Pharmaceuticals, Incorporated | Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
US7211414B2 (en) | 2000-12-01 | 2007-05-01 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
US7109165B2 (en) | 2001-05-18 | 2006-09-19 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
JP4358521B2 (ja) | 2001-05-18 | 2009-11-04 | サーナ・セラピューティクス・インコーポレイテッド | 細胞デリバリーのためのコンジュゲートおよび組成物 |
US9994853B2 (en) | 2001-05-18 | 2018-06-12 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
US20050148530A1 (en) | 2002-02-20 | 2005-07-07 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
US7071311B2 (en) | 2002-02-13 | 2006-07-04 | Sirna Therapeutics, Inc. | Antibodies having specificity for 2′-C-allyl nucleic acids |
GB2413557B (en) * | 2002-02-20 | 2006-08-16 | Sirna Therapeutics Inc | RNA interference mediated inhibtion of gene expression using chemically modified short interfering nucleic acid (siNA) |
US9657294B2 (en) | 2002-02-20 | 2017-05-23 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
GB2406568B (en) * | 2002-02-20 | 2005-09-28 | Sirna Therapeutics Inc | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
US7655790B2 (en) | 2002-07-12 | 2010-02-02 | Sirna Therapeutics, Inc. | Deprotection and purification of oligonucleotides and their derivatives |
US6989442B2 (en) | 2002-07-12 | 2006-01-24 | Sirna Therapeutics, Inc. | Deprotection and purification of oligonucleotides and their derivatives |
DK1527176T4 (en) | 2002-08-05 | 2017-07-03 | Silence Therapeutics Gmbh | ADDITIONAL NEW FORMS OF INTERFERRING RNA MOLECULES |
AU2012216354B2 (en) * | 2002-08-05 | 2016-01-14 | Silence Therapeutics Gmbh | Further novel forms of interfering RNA molecules |
WO2004083432A1 (fr) | 2003-03-21 | 2004-09-30 | Academisch Ziekenhuis Leiden | Modulation de la reconnaissance d'exons dans le pre-arnm par interference avec la structure d'arn secondaire |
EP1622572B1 (fr) | 2003-04-30 | 2017-12-20 | Sirna Therapeutics, Inc. | Conjugues et compositions pour la livraison cellulaire |
ATE452188T1 (de) | 2004-02-10 | 2010-01-15 | Sirna Therapeutics Inc | Rna-interferenz-vermittelte hemmung der genexpression unter verwendung multifunktioneller sina (short interfering nucleic acid) |
US10508277B2 (en) | 2004-05-24 | 2019-12-17 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
EP1799825B1 (fr) * | 2004-10-05 | 2011-06-29 | The California Institute of Technology | Acides nucleiques a regulation d'aptameres et leurs utilisations |
HUE037173T2 (hu) | 2006-08-08 | 2018-08-28 | Univ Bonn Rheinische Friedrich Wilhelms | 5'-Foszfát-oligonukleotidok szerkezete és alkalmazása |
USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
AU2008317566B2 (en) | 2007-10-26 | 2014-05-01 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
EP2119783A1 (fr) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Procédé pour l'omission efficace de l'exon (44) dans la dystrophie musculaire de Duchenne et moyens connexes |
JP5689413B2 (ja) | 2008-05-21 | 2015-03-25 | ライニッシュ フリードリッヒ−ウィルヘルムズ−ユニバーシタット ボン | 平滑末端を有する5’三リン酸オリゴヌクレオチドおよびその使用 |
US20120046342A1 (en) | 2009-04-24 | 2012-02-23 | Prosensa Technologies B.V. | Oligonucleotide comprising an inosine for treating dmd |
CN103140582A (zh) | 2010-08-24 | 2013-06-05 | 默沙东公司 | 含有内部非核酸间隔子的单链RNAi试剂 |
US8871737B2 (en) | 2010-09-22 | 2014-10-28 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
EP3327125B1 (fr) | 2010-10-29 | 2020-08-05 | Sirna Therapeutics, Inc. | Inhibition au moyen d'interférence arn d'une expression de gène utilisant des acides nucléiques à petit interférent (sina) |
EP2508530A1 (fr) | 2011-03-28 | 2012-10-10 | Rheinische Friedrich-Wilhelms-Universität Bonn | Purification d'oligonucléotides triphosphorylés au moyen d'étiquettes de capture |
EP2794630A4 (fr) | 2011-12-22 | 2015-04-01 | Alios Biopharma Inc | Analogues de nucléotide phosphorothioate substitués |
JP2015509922A (ja) | 2012-01-27 | 2015-04-02 | プロセンサ テクノロジーズ ビー.ブイ.Prosensa Technologies B.V. | デュシェンヌ型及びベッカー型筋ジストロフィーの治療のための改善された特徴を有するrna調節オリゴヌクレオチド |
US8916538B2 (en) | 2012-03-21 | 2014-12-23 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
NZ630805A (en) | 2012-03-22 | 2016-01-29 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
US9115160B2 (en) * | 2012-08-31 | 2015-08-25 | Sunny Pharmtech Inc. | Solvent-free process for the preparation of cyclophosphamide |
EP2712870A1 (fr) | 2012-09-27 | 2014-04-02 | Rheinische Friedrich-Wilhelms-Universität Bonn | Nouveaux ligands de RIG-I et procédés pour les produire |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU1775405C (ru) * | 1987-10-29 | 1992-11-15 | Институт цитологии и генетики СО АН СССР | Способ получени 2 @ -дезоксинуклеозид-5 @ -0-(1-тио)трифосфатов |
US4879214A (en) * | 1988-11-15 | 1989-11-07 | E. I. Du Pont De Nemours And Company | Differentiation of nucleic acid segments on the basis of nucleotide differences |
US5610054A (en) * | 1992-05-14 | 1997-03-11 | Ribozyme Pharmaceuticals, Inc. | Enzymatic RNA molecule targeted against Hepatitis C virus |
ATE174600T1 (de) * | 1993-10-27 | 1999-01-15 | Ribozyme Pharm Inc | 2'-amido-und 2'-peptido-modifizierte oligonukleotide |
EP0767657A4 (fr) * | 1994-06-22 | 1999-01-20 | Nexstar Pharmaceuticals Inc | Nouveau procede de production de nucleosides connus et nouveaux, modifies en position 2' par deplacement nucleophile intramoleculaire |
AU4412096A (en) * | 1994-12-13 | 1996-07-03 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
EP1108724B1 (fr) * | 1996-01-16 | 2007-09-19 | Sirna Therpeutics, Inc. | Synthèse de methoxy nucléosides et de molécules d'acide nucléique enzymatique |
CA2288640A1 (fr) * | 1997-05-09 | 1998-11-12 | Ribozyme Pharmaceuticals, Inc. | Traitement a l'acide nucleique enzymatique de maladies et etats pathologiques associes aux niveaux d'expression de c-raf |
-
1999
- 1999-04-28 AU AU38724/99A patent/AU751480B2/en not_active Ceased
- 1999-04-28 JP JP2000546001A patent/JP2002512794A/ja active Pending
- 1999-04-28 CA CA002330574A patent/CA2330574A1/fr not_active Abandoned
- 1999-04-28 EP EP99921537A patent/EP1073732A2/fr not_active Withdrawn
- 1999-04-28 WO PCT/US1999/009348 patent/WO1999055857A2/fr not_active Application Discontinuation
-
2003
- 2003-12-25 JP JP2003429834A patent/JP2004147666A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004147666A (ja) | 2004-05-27 |
AU751480B2 (en) | 2002-08-15 |
AU3872499A (en) | 1999-11-16 |
EP1073732A2 (fr) | 2001-02-07 |
CA2330574A1 (fr) | 1999-11-04 |
WO1999055857A2 (fr) | 1999-11-04 |
WO1999055857A3 (fr) | 2000-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002512794A (ja) | ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み | |
US6617438B1 (en) | Oligoribonucleotides with enzymatic activity | |
US6528640B1 (en) | Synthetic ribonucleic acids with RNAse activity | |
US6057153A (en) | Stabilized external guide sequences | |
US6831171B2 (en) | Nucleic acid catalysts with endonuclease activity | |
JP3529135B2 (ja) | 特定のrna鎖の切断方法 | |
US6127173A (en) | Nucleic acid catalysts with endonuclease activity | |
US6605713B1 (en) | Mirror-symmetrical selection and evolution of nucleic acids | |
US20030004122A1 (en) | Nucleotide triphosphates and their incorporation into oligonucleotides | |
JP2003525017A (ja) | 遺伝子発現を調節しうる新規な化学組成を有する核酸分子 | |
JP2001514873A (ja) | 結合特性が改善されたアンチセンスおよびアンチジーン治療薬並びにそれらの使用方法 | |
WO2001016312A2 (fr) | Modulateurs d'expression genetique a base d'acide nucleique | |
WO1999009216A9 (fr) | Sondes d'acides nucleiques multimeriques hautement sensibles | |
US6797815B2 (en) | Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides | |
WO1998043993A2 (fr) | Acides nucleiques en tant que catalyseurs | |
US6482932B1 (en) | Nucleoside triphosphates and their incorporation into oligonucleotides | |
JP2001507688A (ja) | ヌクレオシド類似体の化学合成とそのポリヌクレオチドへの導入 | |
US6127535A (en) | Nucleoside triphosphates and their incorporation into oligonucleotides | |
AU749561B2 (en) | Nucleic acid molecules having endonuclease and/or catalytic activity | |
EP1493818A2 (fr) | Nucléosides triphosphates et leur intégration aux ribozymes | |
JP2003521943A (ja) | エンドヌクレアーゼ活性を有するヌクレオザイム | |
CA2334161A1 (fr) | Utilisation de molecules d'acide nucleique comme agents antiviraux | |
AU2004200709A1 (en) | Nucleoside Triphosphates and their Incorporation into Ribozymes | |
US20030105308A1 (en) | Nucleoside triphosphates and their incorporation into oligonucleotides | |
KR20010043111A (ko) | C형 간염 바이러스성 감염과 관련된 질환의 효소적 핵산치료제 |